Climb Bio, Inc. (CLYM)
9.18
-0.10
(-1.08%)
USD |
NASDAQ |
Nov 20, 16:00
9.19
+0.01
(+0.11%)
After-Hours: 20:00
Climb Bio Gross Profit (TTM) : -0.296M for Sept. 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.296M |
| June 30, 2026 | -0.13M |
| March 31, 2026 | -0.135M |
| December 31, 2025 | -0.097M |
| September 30, 2025 | -0.067M |
| June 30, 2025 | -0.038M |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Korsana Biosciences, Inc. | -0.033M |
| Cullinan Therapeutics, Inc. | -0.29M |
| Q32 Bio, Inc. | 53.39M |
| Oncolytics Biotech, Inc. | -0.048M |
| Sangamo Therapeutics, Inc. | 28.00M |